Lovastatin
- Product NDC
- 0093-0928
- 11-digit product format
- 000930928
- Labeler code
- 0093
- Product ID
- 0093-0928_caf8172a-311b-447a-8c8b-e9d70c23c8e8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lovastatin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA075551
- Marketing category
- ANDA
- Marketing start
- 2001-12-17
- Substance
- LOVASTATIN
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075551-001 | LOVASTATIN | LOVASTATIN | 40MG | TABLET / ORAL | AB | 2001-12-17 | |
| A075551-002 | LOVASTATIN | LOVASTATIN | 20MG | TABLET / ORAL | AB | 2001-12-17 | |
| A075551-003 | LOVASTATIN | LOVASTATIN | 10MG | TABLET / ORAL | AB | 2001-12-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A075551-001 | AB |
| A075551-002 | AB |
| A075551-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A075551-001 | LOVASTATIN | 40MG | TABLET / ORAL | AB | 2001-12-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A075551-002 | LOVASTATIN | 20MG | TABLET / ORAL | AB | 2001-12-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A075551-003 | LOVASTATIN | 10MG | TABLET / ORAL | AB | 2001-12-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A075551-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A075551-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A075551-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lovastatin | LOVASTATIN | REMEDYREPACK INC. | a902a95f-072a-4487-99a9-109a93f8b23c | 2026-04-03 | Warnings, Adverse reactions | 075551 ANDA075551 |
| Lovastatin | LOVASTATIN | Golden State Medical Supply, Inc. | 91332c54-1a27-4e6b-e053-2a95a90a42cd | 2025-12-15 | Warnings, Adverse reactions | 075551 ANDA075551 |
| Lovastatin | LOVASTATIN | A-S Medication Solutions | 4ff981e8-5c86-4b86-baa1-825551905ed8 | 2024-12-12 | Warnings, Adverse reactions | 075551 ANDA075551 |
| Lovastatin | LOVASTATIN | Aphena Pharma Solutions - Tennessee, LLC | 7e96b174-3887-4908-9b9f-5ef93540f96a | 2023-05-31 | Warnings, Adverse reactions | 075551 ANDA075551 |
| Lovastatin | LOVASTATIN | Teva Pharmaceuticals USA, Inc. | 0e15feec-d27e-4861-8152-c5a8b8ccacd4 | 2020-08-01 | Warnings, Adverse reactions | 075551 ANDA075551 0093-0928 |
| Lovastatin | LOVASTATIN | Proficient Rx LP | 027bd594-6a0a-4e6d-bd3c-4f33fdb4166a | 2020-04-01 | Warnings, Adverse reactions | 075551 ANDA075551 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lovastatin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LOVASTATIN | 40 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9LHU78OQFD | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0e15feec-d27e-4861-8152-c5a8b8ccacd4 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dc9a5fb6-14e2-1cc8-a567-a781fd1f0212 | Product name | 1 | 20140508 |
| f1ae760e-e8ec-b0b4-fb1b-2db7c49fcec5 | Product name | 1 | 20140508 |
| fecc3d5d-ff9a-60ad-1a3a-6cb9b21df758 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0093-0928-06 | Lovastatin | 60 in 1 BOTTLE | TABLET | 60 | 21 | |
| 0093-0928-10 | Lovastatin | 1000 in 1 BOTTLE | TABLET | 1000 | 21 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-0928-06 | EA - Each | 0093-0928 | d8e4e6c2-99c7-4695-b123-a83080615dd6 | 1 | 2012-07-24 |
| 0093-0928-10 | EA - Each | 0093-0928 | 285bb6b7-9cdf-4218-b7a9-683df5a2277f | 1 | 2012-07-24 |
| 0093-0928-19 | EA - Each | 0093-0928 | 7180951f-48c1-4818-b2f9-c6ed6d434019 | 1 | 2012-07-24 |
| 0093-0928-93 | EA - Each | 0093-0928 | fb0d673a-2c8b-4a05-af59-3f5e14b53efe | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0093-0928-06 | 00093092806 | 60 TABLET in 1 BOTTLE (0093-0928-06) | 60 tablet | 2001-12-17 | 0000-00-00 | No | No | Current |
| 0093-0928-10 | 00093092810 | 1000 TABLET in 1 BOTTLE (0093-0928-10) | 1000 tablet | 2001-12-17 | 0000-00-00 | No | No | Current |